Epilepsia · 1992 · 39 citations · 9 references
MedicinePharmacologyPharmacotherapyCalcium HomeostasisEpilepsyNeuropharmacologyAntiepileptic PharmacologyAntiepileptic PharmacotherapyAnticonvulsant ActionAnticonvulsant DrugsAnticonvulsant PharmacologyAntiepileptic Drug EfficacyBlood PressureNimodipine TherapyNimodipine TreatmentSeizures
The influx of Ca2+ into the neuron seems to play an important role in the genesis of epileptic seizures, and current research suggests that calcium entry blockers may have anticonvulsant activity. We used nimodipine, a calcium antagonist with high central nervous system affinity at a fixed dosage of 30 mg, t.i.d., in 21 patients with intractable epilepsy caused by organic brain lesions in addition to basal antiepileptic drug (AED) therapy. After a 12-week treatment period 14 patients (67%) showed a decrease in seizure frequency, four patients had no change, and three had an increase. In eight patients (38%) seizure frequency decreased by greater than 40%. The p value with one-tailed t-test was 0.0491. No significant modifications in AED or electrolyte serum levels were found. One patient had a lowering of blood pressure at this dosage.
9
Double‐Blind Placebo‐Controlled Trial of Flunarizine as Add‐on Therapy in Epilepsy
J. Overweg, C.D. Binnie, J. W. A. Meijer et al. · Epilepsia · 1984 · 134 citations
Open Dose‐Ranging Trial of Flunarizine as Add‐On Therapy in Epilepsy
C. D. Binnie, F. de Beukelaar, J. W. A. Meijer et al. · Epilepsia · 1985 · 63 citations